HOME >> BIOLOGY >> NEWS
Ikerlan-IK4 and Gaiker-IK4 patent device for rapid diagnosis of infectious diseases and cancer

The Ikerlan-IK4 and Gaiker-IK4 Technological Centre have patented a device which is capable of the rapid and effective diagnosis of infectious diseases caused by various bacteria, notable amongst which are Salmonella, Campylobacter and Listeria, the causal agents of most gastroenteritis cases due to food poisoning, as well as of other symptomatologies associated with this condition. With the aim of extending the uses of the device in the field of health, experts at these technological centres are currently researching their application for the detection and treatment of colorectal cancer.

The device incorporates advances in micro-nanotechnologies whereby, in a miniaturised laboratory mode, the required reagents are mixed with a sample of the patient. Thanks to miniaturisation, the result of the analysis is obtained in a matter of minutes very advantageous in providing a rapid and precise diagnosis and one without the need of a laboratory infrastructure which, in turn, enables a speedy start to treatment. Reading of the device will be simple based, as it is, on luminous indicators that tell if the result is positive or negative, the identification corresponding to the presence of specific genetic sequences of the microbian agents causing the pathology or of the cancer patient.

Future applications that this microchip could be used for are of great importance, as they can provide genetic diagnosis tools for doctors to carry out early diagnoses of diseases associated with our genetic inheritance or with the malfunctioning of the mechanisms for the translation of our genetic code such as, possibly, the degenerative pathologies of Parkinsons and Alzheimer, amongst others, or of metabolic disorders. Another field of application of great interest is in the forensic field, medical tests for paternity or even prenatal diagnosis.

In this way, Ikerlan-IK4 and Gaiker-IK4 researchers have focused on colorectal cancer in orde
'"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
24-Jan-2007


Page: 1 2

Related biology news :

1. Jefferson scientists patent dramatically improves
2. Combination Lyme disease vaccine proteins patented
3. NJIT professor obtains patent to uncover trace elements of airborne pollutants
4. Gene hunters, patent prospectors leave indigenous communities in Pacific feeling besieged, betrayed
5. Seminal RNAi innovation is cleared for patenting in Australia
6. NAU receives patent for technique that could stop TB in its tracks
7. Experts urge reform of international patent system at eve of WIPO assembly
8. EPO upholds limited patent on BRCA2 gene
9. European patent awarded for anti-cancer vaccine technology
10. Geneticists oppose singling out Jewish women in European breast cancer patent
11. Virginia Tech patents advance microprocessors, vaccines, vision, vibration control, more

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , ... fibrotic diseases, today announced that Dr. Stacie Canan has joined the company as ... previously served as Executive Director of Global Health at Bristol Myers Squibb (formerly ...
(Date:8/26/2020)... , ... August 25, 2020 , ... Modality Solutions, ... Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking ... 2019 as well, and for this year’s list, reported three-year revenue growth of 71 ...
(Date:8/21/2020)... ... August 19, 2020 , ... ... and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty years. ... published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, ... and CEO has been named one of the 100 most inspiring individuals in ... 100 honorees are selected based on how they have inspired their colleagues and ...
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... the life sciences industry, today announced the release of its signature product ... Medical Science Liaisons (MSLs) and other field medical professionals. , Beacon ...
Breaking Biology Technology:
Cached News: